Should urologists increase use of transperineal prostate biopsies?

Australian researchers have proposed that transperineal (TP) prostate biopsies be offered an option to all men for whom a prostate biopsy is indicated.

The reason, they say, is that TP—although it is more involved and more costly than transrectal ultrasonography (TRUS)-guided biopsy—it is associated with a negligible risk of sepsis, whereas the rate of sepsis resulting from TRUS-guided biopsy is rising, with an increasing proportion of cases involving multidrug-resistant bacteria.

The researchers, led by Jeremy P. Grummet, MBBS, MS, of Monash University, Melbourne, analyzed the outcomes of 245 TP biopsies and found a zero rate of hospital re-admission for sepsis, according to an online report in BJU International.

Renal & Urology News would like to know what urologists think about this, so we invite you to answer the following poll question.